Results for Polychlorinated Biphenyls (PCBs)

You may use, distribute or copy the information in these data tables, with attribution to Biomonitoring California.
For more information, visit our researchers page or contact us.
Results on page last updated:

Chemical Group: Polychlorinated Biphenyls (PCBs)

  • Measured in: Serum

Project: Biomonitoring Exposures Study (BEST) - 1.Pilot

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 066 Lipids ng/g lipid 110 * * * <LOD <LOD 1.45 2.84 38.2% 0.00800 ng/mL
PCB 074 PCB 074 Lipids ng/g lipid 110 3.63 3.12 4.23 1.91 3.27 7.18 13.1 92.7% 0.00800 ng/mL
PCB 099 PCB 099 Lipids ng/g lipid 110 2.89 2.49 3.36 1.61 2.81 4.31 11.9 85.5% 0.00800 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 110 * * * <LOD <LOD 1.36 2.34 28.2% 0.00800 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 110 * * * <LOD <LOD 1.73 4.54 41.8% 0.00800 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 110 4.84 4.10 5.71 2.43 4.14 8.48 19.8 96.4% 0.00800 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 110 9.60 8.11 11.4 5.18 9.81 16.7 43.4 98.2% 0.00800 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 110 22.0 18.5 26.1 12.8 24.7 40.5 99.0 99.1% 0.00800 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 110 3.48 2.99 4.06 1.85 3.66 5.69 13.7 85.5% 0.00800 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 110 6.30 5.36 7.40 3.99 6.85 11.9 23.2 92.7% 0.00800 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 110 21.8 18.2 26.2 13.8 25.7 41.9 79.6 99.1% 0.00800 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 110 2.00 1.75 2.29 <LOD 1.90 3.26 8.51 66.4% 0.00800 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 110 6.38 5.37 7.58 3.60 6.90 11.7 25.0 91.8% 0.00800 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 110 5.24 4.45 6.17 2.96 5.50 9.87 19.2 89.1% 0.00800 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 110 3.15 2.71 3.66 1.55 3.41 5.35 10.8 81.8% 0.00800 ng/mL

Project: Biomonitoring Exposures Study (BEST) - 2.Expanded

Weighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight Notes
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 066 Lipids ng/g lipid 217 * * * <LOD <LOD <LOD 1.94 9.7% 0.00800 ng/mL
PCB 074 PCB 074 Lipids ng/g lipid 217 * * * <LOD <LOD 4.27 11.6 47.1% 0.00800 ng/mL
PCB 099 PCB 099 Lipids ng/g lipid 217 * * * <LOD 1.61 3.10 8.05 58.0% 0.00800 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 217 * * * <LOD <LOD <LOD <LOD 3.5% 0.00800 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 217 * * * <LOD <LOD <LOD 3.47 18.9% 0.00800 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 217 2.85 2.34 3.46 1.29 2.52 4.78 13.4 77.5% 0.00800 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 217 5.11 4.08 6.39 2.32 4.32 10.6 25.6 93.1% 0.00800 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 217 10.1 7.88 12.8 4.00 9.18 26.2 56.5 99.7% 0.00800 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 217 * * * <LOD 1.53 3.45 7.94 52.6% 0.00800 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 217 3.49 2.82 4.32 <LOD 3.50 8.88 16.1 71.7% 0.00800 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 217 9.42 7.26 12.2 3.07 9.40 29.3 54.0 97.7% 0.00800 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 217 * * * <LOD <LOD 2.67 5.13 43.7% 0.00800 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 217 3.14 2.55 3.88 <LOD 2.96 8.63 16.3 69.4% 0.00800 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 217 * * * <LOD 2.08 5.33 11.9 58.8% 0.00800 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 217 * * * <LOD 2.33 5.57 11.5 61.5% 0.00800 ng/mL

Project: California Childhood Leukemia Study (CCLS)

California Childhood Leukemia Study (CCLS) Thumbnail logo shows three young bears in yellow color standing in a row holding hands

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 90th
PCB 028 PCB 28 Lipids ng/g lipid 48 4.1 3.6 4.7 <LOD 3.6 4.3 6.8 100% 0.010 ng/mL
PCB 066 PCB 66 Lipids ng/g lipid 48 2.2 1.9 2.4 1.7 2.3 2.9 3.4 85% 0.010 ng/mL
PCB 074 PCB 74 Lipids ng/g lipid 48 3.0 2.7 3.3 2.4 3.2 3.8 4.2 98% 0.010 ng/mL
PCB 099 PCB 99 Lipids ng/g lipid 48 2.7 2.5 3.1 2.2 3.0 3.5 4.3 90% 0.010 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 48 1.7 1.5 1.9 <LOD 1.8 2.3 2.9 65% 0.010 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 48 1.9 1.7 2.1 <LOD 2.0 2.5 2.7 73% 0.010 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 48 4.0 3.7 4.5 3.2 4.0 5.4 6.7 100% 0.010 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 48 6.8 5.9 7.9 4.8 6.4 9.4 14 100% 0.010 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 48 11 8.9 13 6.5 9.7 17 28 100% 0.010 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 48 2.6 2.3 2.9 1.9 2.5 3.4 4.1 94% 0.010 ng/mL
PCB 167 PCB 167 Lipids ng/g lipid 48 * * * <LOD 1.6 2.1 2.3 60% 0.010 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 48 4.6 4.0 5.3 3.2 4.4 6.6 9.9 100% 0.010 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 48 10 8.4 12 6.1 9.3 15 25 100% 0.010 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 48 2.2 2.0 2.5 1.6 2.4 2.8 3.3 81% 0.011 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 48 3.5 3.1 4.1 2.5 3.4 4.6 7.2 100% 0.010 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 48 3.1 2.8 3.5 2.3 3.2 4.2 5.4 100% 0.010 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 48 3.0 2.7 3.3 2.2 3.1 4.0 5.3 100% 0.010 ng/mL

Project: California Teachers Study (CTS)

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 66 Lipids ng/g lipid 793 * * * <LOD <LOD 1.68 3.07 39.8% 0.015 ng/mL
PCB 074 PCB 74 Lipids ng/g lipid 793 5.96 5.67 6.26 3.84 6.43 9.53 17.7 96.5% 0.015 ng/mL
PCB 099 PCB 99 Lipids ng/g lipid 793 3.11 2.97 3.27 2.01 3.07 4.82 9.73 90.4% 0.015 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 793 * * * <LOD <LOD <LOD <LOD 3.3% 0.015 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 793 * * * <LOD 1.46 2.02 4.39 53% 0.015 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 793 6.5 6.18 6.83 4.09 6.41 10.4 22 99% 0.015 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 793 12.9 12.3 13.5 8.39 13.5 20.5 37.1 99.5% 0.015 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 793 28.7 27.5 30 19.5 30.1 43.6 72.9 100% 0.015 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 793 4.92 4.72 5.12 3.55 5.22 7.23 11.8 96.7% 0.015 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 793 9.18 8.82 9.55 6.68 9.68 13.5 20.7 99.4% 0.015 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 793 31.5 30.3 32.9 22.4 33.3 48.4 76.8 100% 0.015 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 793 2.37 2.27 2.47 1.65 2.4 3.5 5.98 82% 0.015 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 793 7.25 6.92 7.59 4.83 7.65 11.04 20.2 98.4% 0.015 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 793 7.52 7.23 7.83 5.37 7.83 11.09 17.88 99.6% 0.015 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 793 6.47 6.17 6.78 4.36 6.75 10.14 16.71 97.2% 0.015 ng/mL

Project: Firefighter Occupational Exposures (FOX) Project

  • Study Group Subset: Firefighters

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 66 Lipids ng/g lipid 101 1.17 1.09 1.25 <LOD 1.19 1.41 1.88 74.3% 0.007 ng/mL
PCB 074 PCB 74 Lipids ng/g lipid 101 1.77 1.61 1.95 1.33 1.73 2.33 4.02 96.0% 0.005 ng/mL
PCB 099 PCB 99 Lipids ng/g lipid 101 1.76 1.61 1.93 1.34 1.74 2.32 3.65 98.0% 0.005 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 101 * * * <LOD 1.09 1.43 1.89 50.5% 0.008 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 101 * * * <LOD <LOD 0.848 1.25 45.5% 0.005 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 101 2.66 2.46 2.87 2.15 2.75 3.25 5.11 99.0% 0.006 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 101 5.53 4.98 6.15 3.55 5.54 8.04 11.9 100% 0.005 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 101 12.2 10.8 13.7 8.18 12.9 18.9 29.8 100% 0.005 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 101 1.84 1.61 2.09 1.21 1.88 3.09 5.23 88.1% 0.005 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 101 3.64 3.16 4.19 2.21 3.85 5.95 10.3 97.0% 0.005 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 101 13.4 11.7 15.4 8.44 14.7 22.4 37.7 100% 0.006 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 101 1.03 0.930 1.15 <LOD 1.04 1.51 2.33 67.3% 0.005 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 101 2.99 2.61 3.42 1.87 2.94 5.32 7.84 97.0% 0.005 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 101 3.37 2.89 3.93 1.91 3.38 6.04 11.4 98.0% 0.005 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 101 3.37 2.92 3.89 1.91 3.83 6.30 9.37 98.0% 0.005 ng/mL

Project: Maternal and Infant Environmental Exposure Project (MIEEP)

  • Study Group Subset: Pregnant women

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 90th
PCB 066 PCB 66 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD <LOD 0.009 ng/mL
PCB 074 PCB 74 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD 1.1 0.008 ng/mL
PCB 099 PCB 99 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD 2.23 0.014 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD 2.63 0.016 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD <LOD 0.010 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 77 * * * <LOD <LOD 2.02 2.97 0.014 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 77 1.94 1.69 2.22 1.29 1.90 2.63 4.15 0.006 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 77 2.98 2.57 3.46 1.95 3.02 4.29 6.59 0.011 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD 0.89 0.005 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 77 * * * <LOD 0.65 0.92 1.7 0.005 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 77 1.97 1.67 2.31 1.27 1.79 2.90 4.91 0.007 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD <LOD 0.012 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 77 * * * <LOD <LOD 1.2 1.7 0.009 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 77 * * * <LOD <LOD <LOD 1.0 0.007 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 77 * * * <LOD <LOD 0.88 1.4 0.007 ng/mL

Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1

  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Adjusted for Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 90th
PCB 066 PCB 66 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 0% 0.00850 ng/mL
PCB 074 PCB 74 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD 0.992 15.5% 0.00417 ng/mL
PCB 099 PCB 99 Lipids ng/g lipid 58 * * * <LOD <LOD 1.14 1.69 27.6% 0.00733 ng/mL
PCB 101 PCB 101 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 0% 0.0106 ng/mL
PCB 105 PCB 105 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 0% 0.0107 ng/mL
PCB 118 PCB 118 Lipids ng/g lipid 58 1.42 1.25 1.62 <LOD 1.54 2.08 2.59 69.0% 0.00705 ng/mL
PCB 138 PCB 138 Lipids ng/g lipid 58 2.34 1.99 2.74 <LOD 2.37 3.43 5.47 67.2% 0.0107 ng/mL
PCB 153 PCB 153 Lipids ng/g lipid 58 3.16 2.59 3.85 2.05 3.01 5.20 8.05 91.4% 0.00679 ng/mL
PCB 156 PCB 156 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 3.4% 0.0107 ng/mL
PCB 170 PCB 170 Lipids ng/g lipid 58 * * * <LOD 1.64 2.50 2.96 63.8% 0.00696 ng/mL
PCB 180 PCB 180 Lipids ng/g lipid 58 2.94 2.44 3.54 2.00 2.98 4.93 7.09 82.8% 0.00878 ng/mL
PCB 183 PCB 183 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 6.9% 0.0107 ng/mL
PCB 187 PCB 187 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD 2.27 13.8% 0.0107 ng/mL
PCB 194 PCB 194 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD <LOD 8.6% 0.0107 ng/mL
PCB 203 PCB 203 Lipids ng/g lipid 58 * * * <LOD <LOD <LOD 1.55 10.3% 0.0100 ng/mL

Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2

  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 66 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 1.2% 0.0160 and 0.0180 ng/mL**
PCB 074 PCB 74 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 1.7% 0.0160 and 0.0180 ng/mL**
PCB 099 PCB 99 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 3.3% 0.0160 and 0.0180 ng/mL**
PCB 101 PCB 101 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 0.8% 0.0160 and 0.0180 ng/mL**
PCB 105 PCB 105 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 0.8% 0.0160 and 0.0180 ng/mL**
PCB 118 PCB 118 ng/g lipid 242 * * * <LOD <LOD <LOD 3.03 16.9% 0.0160 and 0.0180 ng/mL**
PCB 138 PCB 138 ng/g lipid 242 * * * <LOD 2.50 3.45 5.80 56.2% 0.0160 and 0.0180 ng/mL**
PCB 153 PCB 153 ng/g lipid 242 3.16 2.93 3.41 <LOD 2.89 4.41 8.25 65.3% 0.0160 and 0.0180 ng/mL**
PCB 156 PCB 156 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 2.1% 0.0160 and 0.0180 ng/mL**
PCB 170 PCB 170 ng/g lipid 242 * * * <LOD <LOD <LOD 3.64 18.2% 0.0160 and 0.0180 ng/mL**
PCB 180 PCB 180 ng/g lipid 242 * * * <LOD 2.66 4.04 8.43 59.9% 0.0160 and 0.0180 ng/mL**
PCB 183 PCB 183 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 2.1% 0.0160 and 0.0180 ng/mL**
PCB 187 PCB 187 ng/g lipid 242 * * * <LOD <LOD <LOD 3.29 11.6% 0.0160 and 0.0180 ng/mL**
PCB 194 PCB 194 ng/g lipid 242 * * * <LOD <LOD <LOD <LOD 5.0% 0.0160 and 0.0180 ng/mL**
PCB 203 PCB 203 ng/g lipid 242 * * * <LOD <LOD 2.69 4.35 26.9% 0.0173 and 0.0188 ng/mL**

Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3

  • Study Group Subset: Subsample 1

Unweighted Results

Chemical measured Indicates Exposure to Units Number of people tested Geometric mean 95% Confidence Interval Selected Percentiles Detection Frequency Limit of Detection (LOD), wet-weight
Lower Upper 25th 50th 75th 95th
PCB 066 PCB 66 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 0% 0.0160 ng/mL
PCB 074 PCB 74 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 1.0% 0.0160 ng/mL
PCB 099 PCB 99 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 1.0% 0.0160 ng/mL
PCB 101 PCB 101 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 0% 0.0160 ng/mL
PCB 105 PCB 105 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 0% 0.0160 ng/mL
PCB 118 PCB 118 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 2.0% 0.0160 ng/mL
PCB 138 PCB 138 ng/g lipid 204 * * * <LOD <LOD <LOD 2.80 8.3% 0.0160 ng/mL
PCB 153 PCB 153 ng/g lipid 204 * * * <LOD <LOD 2.44 4.40 27.0% 0.0160 ng/mL
PCB 156 PCB 156 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 1.0% 0.0160 ng/mL
PCB 170 PCB 170 ng/g lipid 204 * * * <LOD <LOD <LOD 2.66 5.4% 0.0160 ng/mL
PCB 180 PCB 180 ng/g lipid 204 * * * <LOD <LOD 3.44 6.90 44.6% 0.0160 ng/mL
PCB 183 PCB 183 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 0% 0.0160 ng/mL
PCB 187 PCB 187 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 4.4% 0.0160 ng/mL
PCB 194 PCB 194 ng/g lipid 204 * * * <LOD <LOD <LOD <LOD 3.4% 0.0160 ng/mL
PCB 203 PCB 203 ng/g lipid 204 * * * <LOD <LOD <LOD 3.08 18.6% 0.0160 ng/mL